SCIENCE OF GLOBAL PROSTATE CANCER DISPARITIES

项目摘要 前列腺癌（CaP）是全球男性第二大常见癌症，也是最常见的男性癌症 在非洲、加勒比海、欧洲和北美。虽然所有黑人都受到不成比例的影响， CaP，非洲裔美国人和牙买加人被认为是世界上CaP发病率最高的人。到 更好地理解和有效地解决不成比例的负担CaP在黑人男子，重要的是， 探索CaP在全球黑人男性中的原因如下：[1]黑人男性之间的祖先联系， 特别是那些与跨大西洋奴隶贸易有关的国家;[2]关于奴隶贸易的文献越来越多， 在加勒比海，欧洲和西方的西非血统的黑人男性中，CaP的负担不成比例 非洲两年一度的黑人男性全球前列腺癌差异科学会议继续 为CaP科学家、临床医生、倡导者和世界各地的幸存者提供了一个聚集在一起的机会 来解决全球黑人中的CaP负担。 第四届两年一度的会议独特地关注在征服黑人前列腺癌方面取得进展 通过探索精准医疗时代的个性化癌症护理。议程设计独特， 促进所有代表之间的有效互动，教育并促进立即传播 幸存者和倡导者的科学。会议将在奥兰多的诺娜湖医疗城举行， 佛罗里达，因为佛罗里达的CaP负担很重。此外，该位置还提供一流的设施， 会议和旅游业。会议将于2016年11月9日至12日举行。会议的主要主办方 是佛罗里达大学，由前列腺癌跨大西洋联盟（CaPTC）共同赞助， 非洲-加勒比癌症联盟（AC 3）和非洲裔男子与前列腺癌 （MADCaP）Consortium.通过其他几个国家和国际组织， 非洲癌症研究和培训组织，佛罗里达中部 药房理事会（CFPC）和黑人男性前列腺癌联盟。

PROJECT SUMMARY Prostate cancer (CaP) is the second most common cancer in men globally and the most common male cancer in Africa, the Caribbean, Europe, and North America. While all Black men are disproportionately affected by CaP, African American and Jamaican men have been noted to have the highest rate of CaP in the world. To better understand and effectively address the disproportionate burden of CaP in Black men, it is important to explore CaP among Black men globally for the following reasons: [1] the ancestral link among Black men, especially those connected by the Transatlantic Slave Trade; and [2] the growing literature on the disproportionate burden of CaP among Black men of West African ancestry in the Caribbean, Europe, and West Africa. The Biennial Science of Global Prostate Cancer Disparities in Black Men Conference continues to provide opportunity for CaP scientists, clinicians, advocates, and survivors all over the world to come together to address the global burden of CaP among Black men. The 4th biennial conference uniquely focuses on making progress in conquering prostate cancer in Black men by exploring personalized cancer care in the era of precision medicine. The agenda has been uniquely designed to foster effective interactions among all delegates, and to educate, and to facilitate immediate dissemination of the science to survivors and advocates. The conference will take place in Lake Nona Medical City, Orlando, Florida because of the significant burden of CaP in Florida. In addition, the location offers excellent facilities for meetings and tourism. The conference will be held November 9-12, 2016. The primary host for the conference is the University of Florida, with co-sponsorship by the Prostate Cancer Transatlantic Consortium (CaPTC), African-Caribbean Cancer Consortium (AC3) and Men of African Descent and Carcinoma of the Prostate (MADCaP) Consortium. There is significant collaborative support through several other national and international organizations, including the: African Organization for Research and Training in Cancer (AORTIC), Central Florida Pharmacy Council (CFPC), and the Black Male Prostate Cancer Coalition.